# Metformin Therapy in Non-diabetic AAA Patients

> **NCT03507413** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 170 (estimated)

## Conditions studied

- Abdominal Aortic Aneurysm

## Interventions

- **DRUG:** Metformin Glucophage 500mg (IR) tablets M90
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03507413
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-26
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2024-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507413, "Metformin Therapy in Non-diabetic AAA Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03507413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*